Position in PFE
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$61,951,021
+$12,417,205 QoQ
Shares Held
2,206,233
+10.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2022CallValue
$155,310
CallShares
3,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LGT Group Foundation holds $1,040,407,974 across 8 Drug Manufacturers - General names. PFE ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,890,121 | $372,769,659 | |
| 2 | LLY |
ELI LILLY & Co
|
399,693 | $367,625,628 | |
| 3 | JNJ |
Johnson & Johnson
|
497,989 | $121,728,428 | |
| 4 | ABBV |
AbbVie Inc.
|
413,651 | $89,964,953 | |
| 5 | PFE |
Pfizer Inc
This page
|
2,206,233 | $61,951,021 | |
| 6 | MRK |
Merck & Co., Inc.
|
194,925 | $23,447,526 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,824 | $1,202,324 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,951,021 | 2,206,233 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $49,533,816 | 1,989,310 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $50,581,289 | 1,985,137 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,856,041 | 1,561,718 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $38,856,378 | 1,533,401 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,321,268 | 916,746 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $22,151,744 | 765,437 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $20,785,640 | 742,875 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $20,107,675 | 724,601 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $19,690,802 | 683,946 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $24,291,084 | 732,321 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $28,053,704 | 764,823 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $30,625,212 | 750,618 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $38,149,100 | 744,518 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $23,610,573 | 539,547 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $38,014,054 | 725,044 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $30,480,309 | 588,764 | Shares | Defined | 2022-05-11 | |
| 2022-03-31 | $155,310 | 3,000 | Call | Defined | 2022-05-11 | |
| 2021-12-31 | $177,150 | 3,000 | Call | Defined | 2022-05-03 | |
| 2021-12-31 | $24,905,693 | 421,773 | Shares | Defined | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||